Trevi Therapeutics Inc (TRVI)

SG&A Expenses

$5.36M

Quarterly · Period ending: · USD

TRVI logo

TRVI SG&A Expenses

Latest reported$5.36M
TRVI Quarterly SG&A Expenses ($624.00K → $5.36M)
High-resolution chart · PNG

TRVI sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
5,357,000
4,971,000
4,027,000
3,831,000
4,333,000
3,659,000
2,877,000
2,863,000
3,230,000
3,067,000
2,380,000
2,722,000
2,540,000
2,563,000
2,340,000
2,636,000
2,717,000
2,380,000
2,094,000
2,229,000
2,669,000
2,500,000
2,633,000
2,416,000
2,492,000
2,620,000
1,943,000
2,000,000
1,889,000
1,474,000
1,406,000
1,210,000
941,000
779,000
624,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.